297 related articles for article (PubMed ID: 12971308)
1. Prostate cancer drugs. Making sense of the options.
Mayo Clin Health Lett; 2003 Aug; 21(8):4-5. PubMed ID: 12971308
[No Abstract] [Full Text] [Related]
2. Multiple intracrine hormonal targets in the prostate: opportunities and challenges.
Labrie F
BJU Int; 2007 Jul; 100 Suppl 2():48-51. PubMed ID: 17594360
[No Abstract] [Full Text] [Related]
3. Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
Koutsilieris M; Dimopoulos T; Milathianakis C; Bogdanos J; Karamanolakis D; Pissimissis N; Halapas A; Lembessis P; Papaioannou A; Sourla A
BJU Int; 2007 Jul; 100 Suppl 2():60-2. PubMed ID: 17594363
[No Abstract] [Full Text] [Related]
4. Advanced prostate cancer. Hormonal treatment.
de la Haba-Rodríguez J
Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
[No Abstract] [Full Text] [Related]
5. Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.
Boudreaux KJ; Chang SS
BJU Int; 2008 Mar; 101(6):671-4. PubMed ID: 18070172
[No Abstract] [Full Text] [Related]
6. [Hot flushes in men after surgical or pharmacologic castration].
Aubert J; Vigouroux V; Doré B
Prog Urol; 1995 Sep; 5(4):507-9. PubMed ID: 7581499
[TBL] [Abstract][Full Text] [Related]
7. Hormonal treatment of prostate cancer.
Garnick MB
N Engl J Med; 1999 Mar; 340(10):812-3. PubMed ID: 10075531
[No Abstract] [Full Text] [Related]
8. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
9. [Hormonal treatment of cancer of the prostate: review and present status].
Ganzer R; Wieland WF; Bach T; Rössler W; Blana A
Dtsch Med Wochenschr; 2007 Jan; 132(4):161-6. PubMed ID: 17230333
[No Abstract] [Full Text] [Related]
10. Nonsteroidal anti-androgens: role in treating advanced prostate cancer.
Newton M; Kosier JH
Urol Nurs; 1998 Mar; 18(1):56-7, 83. PubMed ID: 9582897
[No Abstract] [Full Text] [Related]
11. [Role of hormonotherapy in the treatment of metastatic prostate cancer].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S332-7. PubMed ID: 19070812
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and prostate cancer.
Dacker R
Radiol Technol; 1997; 68(3):194-5. PubMed ID: 9008013
[No Abstract] [Full Text] [Related]
13. Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.
Moul JW
Cancer; 2009 Aug; 115(15):3376-8. PubMed ID: 19484788
[No Abstract] [Full Text] [Related]
14. Endocrine therapy for prostate cancer.
Damber JE
Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
[TBL] [Abstract][Full Text] [Related]
15. Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer.
Kirby RS; Fitzpatrick JM; Clarke N
BJU Int; 2009 Dec; 104(11):1580-4. PubMed ID: 20053189
[TBL] [Abstract][Full Text] [Related]
16. A review of the use of histrelin acetate in the treatment of prostate cancer.
Crawford ED
BJU Int; 2009 Mar; 103 Suppl 2():14-22. PubMed ID: 19228148
[No Abstract] [Full Text] [Related]
17. Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos.
Prescrire Int; 2007 Dec; 16(92):243. PubMed ID: 18092407
[TBL] [Abstract][Full Text] [Related]
18. Complete hormonal blockage--antiandrogens.
Bierkens AF; Debruyne FM
Acta Urol Belg; 1996 May; 64(2):77-9. PubMed ID: 8701818
[No Abstract] [Full Text] [Related]
19. Choosing a prostate cancer drug.
Baker H
Br J Nurs; 2014 Sep 11-24; 23(16):S14, S16. PubMed ID: 25203849
[No Abstract] [Full Text] [Related]
20. The 'flare' phenomenon: should we be concerned?
Thurairaja R; Persad R; Peters J; Bahl A
BJU Int; 2005 Jul; 96(1):4-6. PubMed ID: 15963110
[No Abstract] [Full Text] [Related]
[Next] [New Search]